can you switch from semaglutide to tirzepatide for weight loss I Tirzepatide? What Happens When You Switch

If you miss by several days or a full week, consult your provider about whether to take the missed dose or skip it and resume on schedule

The SELECT trial showed that semaglutide 2.4 mg (Wegovy) reduces cardiovascular risk in adults with established cardiovascular disease and either overweight or obesity, leading to an FDA-approved indication for reducing cardiovascular risk in this population

Younger Skin

Use should be discontinued upon observance of any untoward reaction

UK prescribing is restricted to licensed indications: type 2 diabetes management or weight management in patients meeting specific BMI and comorbidity criteria